Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

The State of the Solar Wind, Magnetosphere, and Ionosphere During the Maunder Minimum.

Riley P, Lionello R, Linker JA, Owens MJ.

Proc Int Astron Union. 2018 Feb;13:247-250. doi: 10.1017/S1743921318001199. Epub 2018 Nov 27.

2.

Chronic Hippocampal Abnormalities and Blunted HPA Axis in an Animal Model of Repeated Unpredictable Stress.

Algamal M, Ojo JO, Lungmus CP, Muza P, Cammarata C, Owens MJ, Mouzon BC, Diamond DM, Mullan M, Crawford F.

Front Behav Neurosci. 2018 Jul 20;12:150. doi: 10.3389/fnbeh.2018.00150. eCollection 2018.

3.

Early Life Stress Associated With Increased Striatal N-Acetyl-Aspartate: Cerebrospinal Fluid Corticotropin-Releasing Factor Concentrations, Hippocampal Volume, Body Mass and Behavioral Correlates.

Coplan JD, Lu D, El Sehamy AM, Tang C, Jackowski AP, Abdallah CG, Nemeroff CB, Owens MJ, Mathew SJ, Gorman JM.

Chronic Stress (Thousand Oaks). 2018 Jan-Dec;2. doi: 10.1177/2470547018768450. Epub 2018 Apr 18.

4.

Probabilistic Solar Wind Forecasting Using Large Ensembles of Near-Sun Conditions With a Simple One-Dimensional "Upwind" Scheme.

Owens MJ, Riley P.

Space Weather. 2017 Nov;15(11):1461-1474. doi: 10.1002/2017SW001679. Epub 2017 Nov 6.

5.

Test-Retest Reliability of the SERT Imaging Agent 11C-HOMADAM in Healthy Humans.

Adhikarla V, Dunlop BW, Jarkas N, Goodman MM, Mayberg H, Owens MJ, Nye JA.

J Nucl Med. 2018 Feb;59(2):315-319. doi: 10.2967/jnumed.117.196915. Epub 2017 Sep 21.

6.

Coronal and heliospheric magnetic flux circulation and its relation to open solar flux evolution.

Lockwood M, Owens MJ, Imber SM, James MK, Bunce EJ, Yeoman TK.

J Geophys Res Space Phys. 2017 Jun;122(6):5870-5894. doi: 10.1002/2016JA023644. Epub 2017 Jun 5.

7.

Coronal mass ejections are not coherent magnetohydrodynamic structures.

Owens MJ, Lockwood M, Barnard LA.

Sci Rep. 2017 Jun 23;7(1):4152. doi: 10.1038/s41598-017-04546-3.

8.

Adult glucocorticoid receptor mRNA expression volatility in response to an acute stressor and juvenile CSF corticotropin-releasing factor: A pilot neurodevelopmental study.

Syed SA, Smith EL, Batuman O, Rosenblum LA, Owens MJ, Nemeroff CB, Coplan JD.

Neurosci Lett. 2017 Apr 24;647:20-25. doi: 10.1016/j.neulet.2017.03.017. Epub 2017 Mar 19.

PMID:
28330718
9.

Global solar wind variations over the last four centuries.

Owens MJ, Lockwood M, Riley P.

Sci Rep. 2017 Jan 31;7:41548. doi: 10.1038/srep41548.

10.

Reduced left ventricular dimension and function following early life stress: A thrifty phenotype hypothesis engendering risk for mood and anxiety disorders.

Coplan JD, Rozenboym AV, Fulton SL, Panthangi V, Tang J, Thiramangalakdi L, Perera TD, Liu Y, Kamran H, Owens MJ, Nemeroff CB, Rosenblum LA, Kral JG, Salciccioli L, Lazar J.

Neurobiol Stress. 2017 Jan 3;8:202-210. doi: 10.1016/j.ynstr.2017.01.001. eCollection 2018 Feb.

11.

Prenatal stress-induced increases in hippocampal von Willebrand factor expression are prevented by concurrent prenatal escitalopram.

Neigh GN, Nemeth CL, Kelly SD, Hardy EE, Bourke C, Stowe ZN, Owens MJ.

Physiol Behav. 2017 Apr 1;172:24-30. doi: 10.1016/j.physbeh.2016.07.009. Epub 2016 Jul 13.

12.

In vivo investigation of escitalopram's allosteric site on the serotonin transporter.

Murray KE, Ressler KJ, Owens MJ.

Pharmacol Biochem Behav. 2016 Feb;141:50-7. doi: 10.1016/j.pbb.2015.11.010. Epub 2015 Nov 24.

13.
14.

Ensemble downscaling in coupled solar wind-magnetosphere modeling for space weather forecasting.

Owens MJ, Horbury TS, Wicks RT, McGregor SL, Savani NP, Xiong M.

Space Weather. 2014 Jun;12(6):395-405. Epub 2014 Jun 9.

15.

Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor.

Stehouwer JS, Birnbaum MS, Voll RJ, Owens MJ, Plott SJ, Bourke CH, Wassef MA, Kilts CD, Goodman MM.

Bioorg Med Chem. 2015 Aug 1;23(15):4286-302. doi: 10.1016/j.bmc.2015.06.036. Epub 2015 Jun 19.

16.

Prenatal stress, regardless of concurrent escitalopram treatment, alters behavior and amygdala gene expression of adolescent female rats.

Ehrlich DE, Neigh GN, Bourke CH, Nemeth CL, Hazra R, Ryan SJ, Rowson S, Jairam N, Sholar CA, Rainnie DG, Stowe ZN, Owens MJ.

Neuropharmacology. 2015 Oct;97:251-8. doi: 10.1016/j.neuropharm.2015.05.012. Epub 2015 May 30.

17.

Early life stress and macaque amygdala hypertrophy: preliminary evidence for a role for the serotonin transporter gene.

Coplan JD, Fathy HM, Jackowski AP, Tang CY, Perera TD, Mathew SJ, Martinez J, Abdallah CG, Dwork AJ, Pantol G, Carpenter D, Gorman JM, Nemeroff CB, Owens MJ, Kaffman A, Kaufman J.

Front Behav Neurosci. 2014 Oct 6;8:342. doi: 10.3389/fnbeh.2014.00342. eCollection 2014.

18.

Prenatal antidepressant exposure: clinical and preclinical findings.

Bourke CH, Stowe ZN, Owens MJ.

Pharmacol Rev. 2014 Feb 24;66(2):435-65. doi: 10.1124/pr.111.005207. Print 2014. Review.

19.

Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects.

Chappell JC, Eisenhofer G, Owens MJ, Haber H, Lachno DR, Dean RA, Knadler MP, Nemeroff CB, Mitchell MI, Detke MJ, Iyengar S, Pangallo B, Lobo ED.

J Clin Psychopharmacol. 2014 Feb;34(1):9-16. doi: 10.1097/JCP.0000000000000061.

PMID:
24346757
20.

Prenatal exposure to escitalopram and/or stress in rats produces limited effects on endocrine, behavioral, or gene expression measures in adult male rats.

Bourke CH, Stowe ZN, Neigh GN, Olson DE, Owens MJ.

Neurotoxicol Teratol. 2013 Sep-Oct;39:100-9. doi: 10.1016/j.ntt.2013.07.008. Epub 2013 Jul 30.

21.

In vivo dialysis setup with a loop injection valve facilitates retrodialysis studies.

Thrivikraman KV, Kinkead B, Murray KE, Owens MJ.

J Pharmacol Toxicol Methods. 2013 Sep-Oct;68(2):217-224. doi: 10.1016/j.vascn.2013.06.002. Epub 2013 Jul 4.

PMID:
23831608
22.

Prenatal exposure to escitalopram and/or stress in rats: a prenatal stress model of maternal depression and its treatment.

Bourke CH, Capello CF, Rogers SM, Yu ML, Boss-Williams KA, Weiss JM, Stowe ZN, Owens MJ.

Psychopharmacology (Berl). 2013 Jul;228(2):231-41. doi: 10.1007/s00213-013-3030-z. Epub 2013 Feb 24. Erratum in: Psychopharmacology (Berl). 2014 Dec;231(23):4583.

23.

Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala.

Flandreau EI, Bourke CH, Ressler KJ, Vale WW, Nemeroff CB, Owens MJ.

Psychoneuroendocrinology. 2013 Aug;38(8):1349-61. doi: 10.1016/j.psyneuen.2012.11.020. Epub 2012 Dec 23.

24.

Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors.

Rye DB, Bliwise DL, Parker K, Trotti LM, Saini P, Fairley J, Freeman A, Garcia PS, Owens MJ, Ritchie JC, Jenkins A.

Sci Transl Med. 2012 Nov 21;4(161):161ra151. doi: 10.1126/scitranslmed.3004685.

25.

Neuroendocrine homeostasis after vagus nerve stimulation in rats.

Thrivikraman KV, Zejnelovic F, Bonsall RW, Owens MJ.

Psychoneuroendocrinology. 2013 Jul;38(7):1067-77. doi: 10.1016/j.psyneuen.2012.10.015. Epub 2012 Nov 16.

PMID:
23159723
26.

Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial.

Dunlop BW, Binder EB, Cubells JF, Goodman MM, Kelley ME, Kinkead B, Kutner M, Nemeroff CB, Newport DJ, Owens MJ, Pace TW, Ritchie JC, Rivera VA, Westen D, Craighead WE, Mayberg HS.

Trials. 2012 Jul 9;13:106. doi: 10.1186/1745-6215-13-106.

27.

Cerebrospinal fluid substance P-like immunoreactivity correlates with aggression in personality disordered subjects.

Coccaro EF, Lee R, Owens MJ, Kinkead B, Nemeroff CB.

Biol Psychiatry. 2012 Aug 1;72(3):238-43. doi: 10.1016/j.biopsych.2012.02.023. Epub 2012 Mar 24.

PMID:
22449753
28.

Depression, antidepressants, and neurogenesis: a critical reappraisal.

Hanson ND, Owens MJ, Nemeroff CB.

Neuropsychopharmacology. 2011 Dec;36(13):2589-602. doi: 10.1038/npp.2011.220. Epub 2011 Sep 21. Review.

29.

Serotonin transporter occupancy in rats exposed to serotonin reuptake inhibitors in utero or via breast milk.

Capello CF, Bourke CH, Ritchie JC, Stowe ZN, Newport DJ, Nemeroff A, Owens MJ.

J Pharmacol Exp Ther. 2011 Oct;339(1):275-85. doi: 10.1124/jpet.111.183855. Epub 2011 Jul 20.

30.
31.

Several stressors fail to reduce adult hippocampal neurogenesis.

Hanson ND, Owens MJ, Boss-Williams KA, Weiss JM, Nemeroff CB.

Psychoneuroendocrinology. 2011 Nov;36(10):1520-9. doi: 10.1016/j.psyneuen.2011.04.006. Epub 2011 May 19.

32.

Metabolic syndrome and neurometabolic asymmetry of hippocampus in adult bonnet monkeys.

Coplan JD, Abdallah CG, Mathew SJ, Shungu DC, Mao X, Smith EL, Kaufman D, Gorman JM, Owens MJ, Nemeroff CB, Banerji MA, Rosenblum LA, Kral JG.

Physiol Behav. 2011 Jul 6;103(5):535-9. doi: 10.1016/j.physbeh.2011.03.020. Epub 2011 Apr 1.

33.

Lithium, but not fluoxetine or the corticotropin-releasing factor receptor 1 receptor antagonist R121919, increases cell proliferation in the adult dentate gyrus.

Hanson ND, Nemeroff CB, Owens MJ.

J Pharmacol Exp Ther. 2011 Apr;337(1):180-6. doi: 10.1124/jpet.110.175372. Epub 2011 Jan 10.

34.

Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine.

Bonne O, Gill JM, Luckenbaugh DA, Collins C, Owens MJ, Alesci S, Neumeister A, Yuan P, Kinkead B, Manji HK, Charney DS, Vythilingam M.

J Clin Psychiatry. 2011 Aug;72(8):1124-8. doi: 10.4088/JCP.09m05106blu. Epub 2010 Dec 28.

PMID:
21208596
35.

Persistent anxiolytic affects after chronic administration of the CRF₁ receptor antagonist R121919 in rats.

Gutman DA, Owens MJ, Thrivikraman KV, Nemeroff CB.

Neuropharmacology. 2011 Jun;60(7-8):1135-41. doi: 10.1016/j.neuropharm.2010.10.004. Epub 2010 Oct 14.

36.

Early-life stress, corticotropin-releasing factor, and serotonin transporter gene: a pilot study.

Coplan JD, Abdallah CG, Kaufman J, Gelernter J, Smith EL, Perera TD, Dwork AJ, Kaffman A, Gorman JM, Rosenblum LA, Owens MJ, Nemeroff CB.

Psychoneuroendocrinology. 2011 Feb;36(2):289-93. doi: 10.1016/j.psyneuen.2010.07.011. Epub 2010 Aug 6.

37.
38.

Changes in the vascular area fraction of the hippocampus and amygdala are induced by prenatal dexamethasone and/or adult stress.

Neigh GN, Owens MJ, Taylor WR, Nemeroff CB.

J Cereb Blood Flow Metab. 2010 Jun;30(6):1100-4. doi: 10.1038/jcbfm.2010.46. Epub 2010 Apr 7.

39.

Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.

Binder EB, Owens MJ, Liu W, Deveau TC, Rush AJ, Trivedi MH, Fava M, Bradley B, Ressler KJ, Nemeroff CB.

Arch Gen Psychiatry. 2010 Apr;67(4):369-79. doi: 10.1001/archgenpsychiatry.2010.18.

PMID:
20368512
40.

A novel transgenic mouse for gene-targeting within cells that express corticotropin-releasing factor.

Martin EI, Ressler KJ, Jasnow AM, Dabrowska J, Hazra R, Rainnie DG, Nemeroff CB, Owens MJ.

Biol Psychiatry. 2010 Jun 15;67(12):1212-6. doi: 10.1016/j.biopsych.2010.01.026. Epub 2010 Mar 29.

41.

Cardiac arrest and cardiopulmonary resuscitation dysregulates the hypothalamic-pituitary-adrenal axis.

Neigh GN, Karelina K, Zhang N, Glasper ER, Owens MJ, Plotsky PM, Nemeroff CB, Devries AC.

J Cereb Blood Flow Metab. 2009 Oct;29(10):1673-82. doi: 10.1038/jcbfm.2009.85. Epub 2009 Jun 24.

42.

The role of serotonin in the pathophysiology of depression: as important as ever.

Nemeroff CB, Owens MJ.

Clin Chem. 2009 Aug;55(8):1578-9. doi: 10.1373/clinchem.2009.123752. Epub 2009 Jun 4. No abstract available.

43.

Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.

Stehouwer JS, Jarkas N, Zeng F, Voll RJ, Williams L, Camp VM, Malveaux EJ, Votaw JR, Howell L, Owens MJ, Goodman MM.

J Med Chem. 2008 Dec 25;51(24):7788-99. doi: 10.1021/jm800781a.

44.

The antidepressant sertraline downregulates Akt and has activity against melanoma cells.

Reddy KK, Lefkove B, Chen LB, Govindarajan B, Carracedo A, Velasco G, Carrillo CO, Bhandarkar SS, Owens MJ, Mechta-Grigoriou F, Arbiser JL.

Pigment Cell Melanoma Res. 2008 Aug;21(4):451-6. doi: 10.1111/j.1755-148X.2008.00481.x.

PMID:
18710373
45.

Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes.

Keen-Rhinehart E, Michopoulos V, Toufexis DJ, Martin EI, Nair H, Ressler KJ, Davis M, Owens MJ, Nemeroff CB, Wilson ME.

Mol Psychiatry. 2009 Jan;14(1):37-50. doi: 10.1038/mp.2008.91. Epub 2008 Aug 12.

46.

Behavioral effects of the CRF1 receptor antagonist R121919 in rats selectively bred for high and low activity in the swim test.

Gutman DA, Coyer MJ, Boss-Williams KA, Owens MJ, Nemeroff CB, Weiss JM.

Psychoneuroendocrinology. 2008 Sep;33(8):1093-101. doi: 10.1016/j.psyneuen.2008.05.003. Epub 2008 Aug 3. Erratum in: Psychoneuroendocrinology. 2009 May;34(4):630-1.

PMID:
18676086
47.

Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine.

Owens MJ, Krulewicz S, Simon JS, Sheehan DV, Thase ME, Carpenter DJ, Plott SJ, Nemeroff CB.

Neuropsychopharmacology. 2008 Dec;33(13):3201-12. doi: 10.1038/npp.2008.47. Epub 2008 Apr 16.

48.

Endogenous neurotensin is involved in estrous cycle related alterations in prepulse inhibition of the acoustic startle reflex in female rats.

Kinkead B, Yan F, Owens MJ, Nemeroff CB.

Psychoneuroendocrinology. 2008 Feb;33(2):178-87. Epub 2007 Dec 21.

49.

Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.

Zeng F, Jarkas N, Stehouwer JS, Voll RJ, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM.

Bioorg Med Chem. 2008 Jan 15;16(2):783-93. Epub 2007 Oct 13.

PMID:
17983754
50.

Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy.

Carpenter LL, Bayat L, Moreno F, Kling MA, Price LH, Tyrka AR, Kinkead B, Owens MJ, Nemeroff CB.

Psychiatry Res. 2008 Jan 15;157(1-3):123-9. Epub 2007 Oct 31.

PMID:
17976740

Supplemental Content

Loading ...
Support Center